Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Gilead plans to provide $1.1 million annually for five years to the Institute of Organic Chemistry & Biochemistry at the Academy of Sciences of the Czech Republic (IOCB) to help establish a research facility. Gilead has licensing agreements with IOCB and the Rega Institute for Medical Research at Belgium's Katholic University dating back to 1991 for a range of nucleotide analog compounds and structures. Several of them have been developed by Gilead, resulting in the HIV treatment Viread and other drugs.
This article has been sent to the following recipient: